Scientific article
English

Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

CollaboratorsChizzolini, Carlo
Published inArthritis and Rheumatology, vol. 70, no. 11, p. 1829-1834
Publication date2018
Abstract

Data on the role of tobacco exposure in systemic sclerosis (SSc; scleroderma) severity and progression are scarce. We aimed to assess the effects of smoking on the evolution of pulmonary and skin manifestations, based on the European Scleroderma Trials and Research group database.

Keywords
  • Adult
  • Aged
  • Autoantibodies/immunology
  • DNA Topoisomerases/immunology
  • Disease Progression
  • Ex-Smokers
  • Female
  • Forced Expiratory Volume
  • Humans
  • Linear Models
  • Logistic Models
  • Longitudinal Studies
  • Lung/physiopathology
  • Male
  • Middle Aged
  • Non-Smokers
  • Scleroderma
  • Systemic/immunology/pathology/physiopathology
  • Severity of Illness Index
  • Skin/pathology
  • Smokers
  • Smoking/immunology/pathology/physiopathology
  • Vital Capacity
Citation (ISO format)
JAEGER, Veronika K et al. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study. In: Arthritis and Rheumatology, 2018, vol. 70, n° 11, p. 1829–1834. doi: 10.1002/art.40557
Main files (1)
Article (Published version)
accessLevelRestricted
Secondary files (1)
Identifiers
Additional URL for this publicationhttp://eprints.whiterose.ac.uk/136096/
Journal ISSN2326-5191
305views
0downloads

Technical informations

Creation11/07/2019 10:17:00 AM
First validation11/07/2019 10:17:00 AM
Update time03/15/2023 6:39:38 PM
Status update03/15/2023 6:39:36 PM
Last indexation10/31/2024 5:28:00 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack